| # | Country | Total Patents | |
|---|---|---|---|
| #1 | China | 3 | |
| #2 | EPO (European Patent Office) | 2 | |
| #3 | Taiwan | 2 | |
| #4 | Canada | 1 | |
| #5 | Republic of Korea | 1 | |
| #6 | New Zealand | 1 | |
| #7 | United States | 1 | |
| #8 | WIPO (World Intellectual Property Organization) | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Micro-structure and nano-technology | |
| #4 | Machines | |
| #5 | Medical technology |
| # | Technology | |
|---|---|---|
| #1 | Peptides | |
| #2 | Medical preparations | |
| #3 | Therapeutic chemical compounds | |
| #4 | Nanostructure applications | |
| #5 | Unspecified technologies | |
| #6 | Object sterilising |
| # | Name | Total Patents |
|---|---|---|
| #1 | Hsia Jen-Chang | 8 |
| #2 | Chang Hsia Jen | 2 |
| #3 | Hsia Jen Chang | 1 |
| #4 | Jen-Chang Hsia | 1 |
| Publication | Filing date | Title |
|---|---|---|
| TW381022B | Compositions and methods utilizing nitroxides to avoid oxygen toxicity, particularly in stabilized, polymerized, conjugated, or encapsulated hemoglobin used as a red cell substitute | |
| US4857636A | Pasteurizable, freeze-driable hemoglobin-based blood substitute |